Dr. Melanie Bahlo, Walter and Eliza Hall Institute (IMAGE)
Caption
Dr. Melanie Bahlo from the Walter and Eliza Hall Institute is part of an international team that has discovered a genetic variation that could identify those people infected with hepatitis C who are most likely to benefit from current treatments.
Credit
Walter and Eliza Hall Institute
Usage Restrictions
None
License
Licensed content